FVL gene mutation increases risk of blood clots in breast cancer patients treated wit

[News]

Women who develop blood clots while taking tamoxifen for early-stage breast cancer are more likely to carry a faulty version of a gene involved in clotting than those who do not develop blood clots, a US study has found.

More... (http://www.news-medical.net/news/20100618/FVL-gene-mutation-increases-risk-of-blood-clots-in-breast-cancer-patients-treated-with-tamoxifen-Study.aspx)